linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Piramal Pharma Ltd.
 
Source DateBoard Meeting DateDetails
24 Oct 202505 Nov 2025 Quarterly Results
18 Jul 202528 Jul 2025 Quarterly Results
29 Apr 202514 May 2025 Final Dividend & Audited Results
13 Jan 202528 Jan 2025 Quarterly Results
14 Oct 202423 Oct 2024 Quarterly Results
15 Jul 202426 Jul 2024 Quarterly Results
30 Apr 202410 May 2024 Final Dividend & Audited Results
17 Jan 202430 Jan 2024 Quarterly Results
18 Oct 202327 Oct 2023 Quarterly Results
28 Jul 202303 Aug 2023 Quarterly Results
18 May 202324 May 2023 Audited Results
01 Feb 202308 Feb 2023 Rights Issue & Quarterly Results
01 Nov 202208 Nov 2022 Quarterly Results
Page 1 of 1
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.